知识产权和新兴技术

这种独特而全面的收集调查由生物学研究的范式转变带来知识产权的挑战。它探讨了新兴技术，如基因组学，合成生物学，干细胞研究，纳米技术，生物发现和的法律后果。

Extensive contributions examine recent controversial court decisions in patent law – such as Bilski v. Kappos, and the litigation over Myriad’s patents in respect of BRCA1 and BRCA2 – while other papers explore sui generis fields, such as access to genetic resources, plant breeders’ rights, and traditional knowledge. The collection considers the potential and the risks of the new biology for global challenges – such as access to health-care, the protection of the environment and biodiversity, climate change, and food security. It also considers Big Science projects – such as biobanks, the 1000 Genomes Project, and the Doomsday Vault. The inter-disciplinary research brings together the work of scholars from Australia, Canada, Europe, the UK, and the US and involves not only legal analysis of case law and policy developments, but also historical, comparative, sociological, and ethical methodologies.

知识产权和新兴技术将吸引政策制定者、法律从业者、商业经理、发明家、科学家和研究人员。